Literature DB >> 25022198

Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV prevention.

Heather A Pines1, Pamina M Gorbach, Cathy J Reback, Raphael J Landovitz, Matt G Mutchler, Ronald Mitsuyasu.   

Abstract

To inform the development and assess potential use of rectal microbicide gels for HIV prevention among men who have sex with men (MSM), we examined the dynamics and contexts of commercial lubricant use during receptive anal intercourse (RAI) within this population. From 2007 to 2010, 168 HIV-negative MSM living in Los Angeles who practice RAI completed computer-assisted self-interviews, which collected information on their last sexual event with ≤3 recent partners, at baseline, three months, and one-year study visits. Logistic generalized linear mixed models were used to identify individual- and sexual event-level characteristics associated with commercial lubricant use during RAI at the last sexual event within 421 partnerships reported by participants over the course of follow-up. During RAI at their last sexual event, 57% of partnerships used a condom and 69% used commercial lubricant. Among partnerships that used commercial lubricant, 56% reported lubricant application by both members of the partnership, 66% first applied lubricant during sex, but before penetration, and 98% applied lubricant at multiple locations. The relationship between substance use and commercial lubricant use varied by condom use (interaction p-value = 0.01). Substance use was positively associated with commercial lubricant use within partnerships that did not use condoms during RAI at their last sexual event (AOR = 4.47, 95% [corrected] [CI]: 1.63-12.28), but no association was observed within partnerships that did use condoms (AOR = 0.66, 95% CI: 0.23-1.85). Commercial lubricant use during RAI was also positively associated with reporting more sexual partners (AOR = 1.18, 95% CI: 1.05-1.31), while older age (units = 5 years; AOR = 0.75, 95% CI: 0.61-0.94), homelessness (past year; AOR = 0.32, 95% CI: 0.13-0.76), and having sex with an older (>10 years) partner (AOR = 0.37, 95% CI: 0.14-0.95) were negatively associated with commercial lubricant use. These factors should be considered in the development of rectal microbicide gels to enhance their acceptability and use among MSM.

Entities:  

Keywords:  HIV prevention; MSM; MSM partnerships; commercial lubricant use; receptive anal intercourse; rectal microbicides

Mesh:

Substances:

Year:  2014        PMID: 25022198      PMCID: PMC4188690          DOI: 10.1080/09540121.2014.936821

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  31 in total

1.  Commentary: probability of HIV transmission through anal intercourse.

Authors:  Andrew E Grulich; Iryna Zablotska
Journal:  Int J Epidemiol       Date:  2010-05-28       Impact factor: 7.196

2.  Lubricant use among men who have sex with men reporting receptive anal intercourse in Peru: implications for rectal microbicides as an HIV prevention strategy.

Authors:  J J Kinsler; J T Galea; J Peinado; P Segura; S M Montano; J Sánchez
Journal:  Int J STD AIDS       Date:  2010-08       Impact factor: 1.359

3.  Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities.

Authors:  Patrick S Sullivan; Laura Salazar; Susan Buchbinder; Travis H Sanchez
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

4.  Preference and practices relating to lubricant use during anal intercourse: implications for rectal microbicides.

Authors:  Marjan Javanbakht; Ryan Murphy; Pamina Gorbach; Marc-André LeBlanc; Jim Pickett
Journal:  Sex Health       Date:  2010-06       Impact factor: 2.706

5.  Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART.

Authors:  Fengyi Jin; James Jansson; Matthew Law; Garrett P Prestage; Iryna Zablotska; John C G Imrie; Susan C Kippax; John M Kaldor; Andrew E Grulich; David P Wilson
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

6.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

Review 7.  HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention.

Authors:  Rebecca F Baggaley; Richard G White; Marie-Claude Boily
Journal:  Int J Epidemiol       Date:  2010-04-20       Impact factor: 7.196

8.  Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men.

Authors:  A Carballo-Diéguez; C Dolezal; J A Bauermeister; W O'Brien; A Ventuneac; K Mayer
Journal:  Sex Transm Infect       Date:  2008-11       Impact factor: 3.519

9.  Estimated HIV incidence in the United States, 2006-2009.

Authors:  Joseph Prejean; Ruiguang Song; Angela Hernandez; Rebecca Ziebell; Timothy Green; Frances Walker; Lillian S Lin; Qian An; Jonathan Mermin; Amy Lansky; H Irene Hall
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

10.  Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.

Authors:  Ana Ventuneac; Alex Carballo-Diéguez; Ian McGowan; Robert Dennis; Amy Adler; Elena Khanukhova; Charles Price; Terry Saunders; Chomchay Siboliban; Peter Anton
Journal:  AIDS Behav       Date:  2009-09-11
View more
  6 in total

1.  Individual-Level, Partnership-Level, and Sexual Event-Level Predictors of Condom Use During Receptive Anal Intercourse Among HIV-Negative Men Who Have Sex with Men in Los Angeles.

Authors:  Heather A Pines; Pamina M Gorbach; Robert E Weiss; Cathy J Reback; Raphael J Landovitz; Matt G Mutchler; Ronald T Mitsuyasu
Journal:  AIDS Behav       Date:  2016-06

2.  Lubricant Provides Poor Rectal Mucosal HIV Coverage.

Authors:  Eugenie C Shieh; Ethel D Weld; Edward J Fuchs; Hiwot Hiruy; Karen W Buckheit; Robert W Buckheit; Jennifer Breakey; Craig W Hendrix
Journal:  AIDS Res Hum Retroviruses       Date:  2017-07-24       Impact factor: 2.205

3.  Pleasure, affection, and love among Black men who have sex with men (MSM) versus MSM of other races: countering dehumanizing stereotypes via cross-race comparisons of reported sexual experience at last sexual event.

Authors:  Sarah K Calabrese; Joshua G Rosenberger; Vanessa R Schick; David S Novak
Journal:  Arch Sex Behav       Date:  2015-01-21

4.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12

5.  Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse.

Authors:  Timothy Frasca; Rebecca Giguere; Mobolaji Ibitoye; Curtis Dolezal; Irma Febo; Ross D Cranston; Kenneth Mayer; Ian McGowan; Alex Carballo-Diéguez
Journal:  Arch Sex Behav       Date:  2016-04-29

6.  Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression.

Authors:  Laura Romas; Kenzie Birse; Kenneth H Mayer; Max Abou; Garrett Westmacott; Rebecca Giguere; Irma Febo; Ross D Cranston; Alex Carballo-Diéguez; Ian McGowan; Adam Burgener
Journal:  AIDS Res Hum Retroviruses       Date:  2016-08-02       Impact factor: 2.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.